期刊文献+

抗感染血管移植物研究进展

Research progress in anti-infective vascular grafts
原文传递
导出
摘要 血管移植物感染是血管移植术后发生的严重并发症。为治疗感染,需使用抗生素进行保守治疗,或再次手术移除感染移植物,但这会给患者造成二次伤害。为减轻患者痛苦,预防和治疗血管移植物感染,抗菌血管移植物被广泛研究。目前移植物的抗菌策略主要有三种,包括抗菌物质浸渍血管移植物、在移植物表面构建抗菌涂层以及将抗菌物质混合在基底材料中制备抗菌移植物。基于此,本文展开介绍以上三种制备抗菌血管移植物策略的研究进展,并对未来进行展望。 Vascular graft infection is a severe complication caused by vascular transplantation.To treat infection,conservative measures involving the use of antibiotics are typically employed.However,in some cases,re-surgery may be necessary to remove the infected graft,which may result in secondary damage to the patient.To alleviate patient's discomfort and prevent/treat vascular graft infections,antibacterial vascular grafts have been widely studied.Currently,there are three main antibacterial strategies for vascular grafts,including impregnating vascular grafts with antibacterial substances,constructing antibacterial coatings on the surface of the graft,and preparing antibacterial grafts by mixing antibacterial substances in the substrate material.Based on this,this article will introduce the research progress of the above three strategies for developing antibacterial vascular grafts and provide insights into future prospects.
作者 李杨 赵纪春 王云兵 Li Yang;Zhao Jichun;Wang Yunbing(Department of Vascular Surgery,West China Hospital of Sichuan University,Chengdu 610041,China;National Engineering Research Center for Biomaterials,Sichuan University,Chengdu 610064,China)
出处 《中华血管外科杂志》 2024年第1期51-55,共5页 Chinese Journal of Vascular Surgery
关键词 血管移植物 抗感染 生物材料 Vascular grafts Anti-infection Biomaterial
  • 相关文献

参考文献3

二级参考文献41

  • 1贾鑫,郭伟,刘小平,梁发启,尹太,马晓辉,熊江.感染性腹主动脉瘤的外科治疗[J].中华临床医师杂志(电子版),2011,5(9):2624-2627. 被引量:11
  • 2戈小虎,方青波,管圣,赛里木,任昊,田广磊.感染性腹主动脉瘤诊疗体会[J].中国血管外科杂志(电子版),2012,4(4):229-231. 被引量:14
  • 3肖占祥.感染性腹主动脉瘤的治疗探讨[J].中国血管外科杂志(电子版),2014,6(4):200-201. 被引量:6
  • 4汪忠镐.中国血管外科研究20年:从血管组织工程样(生物化人工血管)研究到干细胞移植[J].中国临床康复,2005,9(22):89-96. 被引量:8
  • 5Braithwaite BD,Davies B,Heather BP,et al.Early results of a randomized trial of rifampicin-bonded Dacon grafts for extra-anatomic vascular reconstruction.Joint vascular research group[J].Br J Surg,1998,85:1378-1381.
  • 6Powell TW,Burnham SJ,Johnson G Jr.A passive system using rifampin to create an infection-resistant vascular prosthesis[J].Surgery,1983,94:765-769.
  • 7McDougal EG,Burnham SJ,Johnson G Jr.Rifampin protection against experimental graft sepsis[J].J Vasc Surg,1986,4:5-7.
  • 8Chervu A,Moore WS,Gelabert HA,et al.Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system[J].J Vasc Surg,1991,14:521-525.
  • 9Colburn MD,Moore WS,Chvapil M,et al.Use of an antibiotic-bonded graft for in situ reconstruction after prosthetic graft infections[J].J Vasc Surg,1992,16:651-660.
  • 10Pratesi C,Russo D,Dorigo W,et al.Antibiotic prophylaxis in clean surgery:vascular surgery[J].J Chemother,2001,1:123-128.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部